Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 7, 2025 • 11:01 PM ET

Date/Time Source News Release
08/20/2021 09:00 AM EDT GlobeNewswire Vitality Biopharma Enters Into $5 Million Equity Line Financing Relationship With Institutional Investor
08/10/2021 09:00 AM EDT GlobeNewswire FDA Grants Vitality Biopharma Orphan Drug Designation for VBX-100 Prodrug
09/25/2020 09:00 AM EDT GlobeNewswire Vitality Biopharma Retains DelMorgan & Co. to Explore Strategic Alternatives
04/27/2020 04:52 PM EDT GlobeNewswire Vitality Biopharma Board Update
05/14/2019 09:00 AM EDT GlobeNewswire Vitality Biopharma Welcomes New Executive Management Team
04/25/2019 12:00 PM EDT GlobeNewswire Vitality Biopharma Co-Founder Dr. Avtar Dhillon Resigns from Board of Directors
01/24/2019 03:56 PM EST GlobeNewswire Vitality Biopharma Appoints Former Ohio Governor Richard F. Celeste to Board
12/03/2018 08:00 AM EST GlobeNewswire Vitality Biopharma to Present at the 11th Annual LD Micro Main Event
11/21/2018 07:00 AM EST GlobeNewswire Vitality Biopharma Announces Corporate Updates and Completion of an SEC Examination
10/23/2018 07:00 AM EDT GlobeNewswire Vitality Biopharma Receives $8.5 Million Common Stock Financing
Page

Additional News

As of July 7, 2025 • 11:01 PM ET

Date/Time Source News Release
08/20/2021 09:13 AM EDT SeekingAlpha Vitality Biopharma enters $5M equity line financing
11/07/2018 09:00 AM EST ACCESSWIRE IA SeeThruEquity Issues Update on Vitality Biopharma (VBIO) with Target Price of $3.50
10/16/2018 08:20 AM EDT ACCESSWIRE IA Vitality Biopharma Tackling the Medical Benefits of Cannabis with a Diverse Pipeline
09/13/2018 09:00 AM EDT CannabisNewsWire The CBD Bonanza on the Horizon
04/16/2018 08:30 AM EDT Livemoney Vitality Biopharma Sparks Canadian Cannabinoid Genetics R
03/28/2018 09:22 AM EDT Livemoney Revolutionary Cannabinoid Prodrug Goes Global with International Patent Prosecution
02/28/2018 08:30 AM EST ACCESSWIRE IA The Story Behind Growth: New Report Discusses Vitality Biopharma and Growlife - Emerging Trends Within New Industry
01/30/2018 09:00 AM EST ACCESSWIRE IA SeeThruEquity Issues Update on Vitality Biopharma, Inc. (VBIO)
01/29/2018 02:01 PM EST Livemoney US Market Commentary A New, Non-Corrosive, Non-Irritating Treatment for Pediatric Ulcerative Colitis Has Been Submitted for FDA's Orphan Drug Classification
01/23/2018 05:02 AM EST Pot News Vitality Biopharma Applies for Orphan Drug Status
Page
  • 1
  • 2

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.